European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Roxadustat

Ads

You May Also Like

Genocea Biosciences Reports Second Quarter 2017 Financial Results

- Recently reported positive top-line 12-month Phase 2b data for GEN-003 in genital herpes ...

Clearside Biomedical, Inc. Announces Proposed Offering of Common Stock

ALPHARETTA, Ga., Dec. 07, 2016 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical ...

Alcobra Ltd. and Arcturus Therapeutics, Inc. Agree to Merge

Transaction to result in NASDAQ-listed company focused on developing novel RNA medicines and technologiesArcturus ...